N2AR34 Stock Overview
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Inari Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$50.94 |
| 52 Week High | US$52.15 |
| 52 Week Low | US$47.82 |
| Beta | 1.26 |
| 1 Month Change | 0% |
| 3 Month Change | -1.47% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 43.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| N2AR34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 0.5% |
| 1Y | n/a | 1.7% | 8.9% |
Return vs Industry: Insufficient data to determine how N2AR34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how N2AR34 performed against the BR Market.
Price Volatility
| N2AR34 volatility | |
|---|---|
| N2AR34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in BR Market | 9.4% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: N2AR34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine N2AR34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 800 | Bill Hoffman | www.inarimedical.com |
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
Inari Medical, Inc. Fundamentals Summary
| N2AR34 fundamental statistics | |
|---|---|
| Market cap | R$21.84b |
| Earnings (TTM) | -R$80.10m |
| Revenue (TTM) | R$1.79b |
12.2x
P/S Ratio-272.6x
P/E RatioIs N2AR34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| N2AR34 income statement (TTM) | |
|---|---|
| Revenue | US$335.63m |
| Cost of Revenue | US$35.63m |
| Gross Profit | US$300.00m |
| Other Expenses | US$315.01m |
| Earnings | -US$15.01m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 02, 2022
| Earnings per share (EPS) | -0.28 |
| Gross Margin | 89.38% |
| Net Profit Margin | -4.47% |
| Debt/Equity Ratio | 0% |
How did N2AR34 perform over the long term?
See historical performance and comparison